Changes in antidepressant use by young people and suicidal behavior after FDA warnings and media coverage: quasi-experimental study - Wikidata - awgldk - TriplyDB

Changes in antidepressant use by young people and suicidal behavior after FDA warnings and media coverage: quasi-experimental study

Changes in antidepressant use by young people and suicidal behavior after FDA warnings and media coverage: quasi-experimental study

http://www.wikidata.org/entity/Q33774659

about

Interventions for self-harm in children and adolescents Selective Serotonin Reuptake Inhibitors and Violent Crime: A Cohort Study Missing clinical and behavioral health data in a large electronic health record (EHR) system Antidepressants and the adolescent brain.Suicide and suicidal behaviour Status Update on the Sheehan-Suicidality Tracking Scale (S-STS) 2014 Racial/Ethnic differences in health care visits made before suicide attempt across the United States.Utilization of oral antidiabetic medications in Taiwan following strategies to promote access to medicines for chronic diseases in community pharmacies The role of 5-HT1A receptors in mediating acute negative effects of antidepressants: implications in pediatric depression.Depression and violence: a Swedish population study.Effect of Pediatric Behavioral Health Screening and Colocated Services on Ambulatory and Inpatient Utilization Suicide Behavior Before and After the Start with Antidepressants: A High Persistent Risk in the First Month of Treatment Among the Young Asthma Treatments and Mental Health Visits After a Food and Drug Administration Label Change for Leukotriene Inhibitors How Did Multiple FDA Actions Affect the Utilization and Reimbursed Costs of Thiazolidinediones in US Medicaid?Influences on antidepressant prescribing trends in the UK: 1995-2011.Excess mortality in bipolar disorders.Capsule commentary on Ott et al., do statins impair cognition? A systematic review and meta-analysis of randomized controlled trials Are antidepressants effective? A debate on their efficacy for the treatment of major depression in adults.Predictors of and attitudes toward counseling about SUDEP and other epilepsy risk factors among Austrian, German, and Swiss neurologists and neuropediatricians.Outpatient antidepressant drug use in children and adolescents in Germany between 2004 and 2011.Recent Advances in Means Safety as a Suicide Prevention Strategy.Comparative risk of self-harm hospitalization amongst depressive disorder patients using different antidepressants: a population-based cohort study in Taiwan.The Impact of the Massachusetts Behavioral Health Child Screening Policy on Service Utilization.The Impact of High-Profile Sexual Abuse Cases in the Media on a Pediatric Emergency Department.The Impact of FDA Regulatory Activities on Incident Dispensing of LABA-Containing Medication: 2005-2011.Effects of safety warnings and risk management plan for Thiazolidinediones in Taiwan.Comparing episodes of antidepressants use with intermittent episodes of no use: A higher relative risk of suicide attempts but not of suicide at young age.Antidepressant drugs and teenage suicide in Hungary: Time trend and seasonality analysis.Linguistic Validation of the Pediatric Versions of the Sheehan Suicidality Tracking Scale (S-STS).Link between FDA antidepressant warnings and increased suicide attempts in young people is questionable.Psychotropic Medication Use among Insured Children with Autism Spectrum Disorder.Effect of Early-Life Fluoxetine on Anxiety-Like Behaviors in BDNF Val66Met Mice.Long-Run Trends in Antidepressant Use Among Youths After the FDA Black Box Warning.A decline in depression treatment following FDA antidepressant warnings largely explains racial/ethnic disparities in prescription fills.Acute fluoxetine modulates emotional processing in young adult volunteers.Measures of suicidality in phase 3 clinical trials of levomilnacipran ER in adults with major depressive disorder.Antidepressant Regulatory Warnings, Prescription Patterns, Suicidality and Other Aggressive Behaviors in Major Depressive Disorder and Anxiety Disorders.Impact of pioglitazone regulatory withdrawal on antidiabetic drug use and health in diabetic patients.The Role of HIPAA Omnibus Rules in Reducing the Frequency of Medical Data Breaches: Insights From an Empirical Study.Near Real-time Surveillance for Consequences of Health Policies Using Sequential Analysis.

P2860

Q24187033-6796D789-45FE-4AE7-9672-4A7F252C0B69 Q28548023-7962C775-27D7-46FD-83FB-D63EC4A8EEAA Q31077469-76E46C43-032D-4BFE-949F-836B972F0822 Q34465941-01C0F936-B67A-48B0-8F21-72FF17BC4766 Q34494779-97A34120-B35A-4EB8-9E83-444D45009854 Q34713076-76946C3E-12C2-410F-B8B1-38FBBB91B6C9 Q35424324-6311BC1B-E178-468A-83F6-8FC2269D21A7 Q35576740-A1ACB451-22E6-4CE9-BC29-70FD71B858A5 Q35753190-C6114EF9-3694-4CB6-8515-F4C290908695 Q35903667-B6CFE068-1B8B-4CD4-A613-8A4F0617DC16 Q36250015-98B994E7-3798-4FB1-BC3E-6D0F0B94978E Q36635612-45EA834E-479D-444C-987B-D4A79B03BB07 Q37402764-C623AD0B-A76B-4B97-9EBD-87F01C085DEA Q37545937-13A1A5BD-BC55-4733-A40E-79B7A23175D0 Q37670602-F3A29E1C-157D-4814-ABEA-3D4C7A454AC2 Q38246512-86A77723-4382-4EF1-91DE-C8F7145A71B7 Q38333339-5840992E-9C9E-4622-A23F-7B8B2BD2B772 Q38739261-23764336-8437-46C9-B45E-8CE0AC392862 Q38743191-2DC8AFAD-47FD-460D-AFF7-4F75A6EFD3EB Q38792908-32AA55D7-29C5-4224-AC77-980F90A174F8 Q38954639-043905B1-80B7-4144-9300-6561918AF9C8 Q39360265-0829EC29-3335-47BF-A809-D323B99292FF Q39434026-159D7699-1BEE-4E1F-A44E-62232F478F8B Q39453996-2A305AD1-84AB-4F18-BEB5-EC6BD4543D58 Q40041139-2FC08B7A-E586-442B-BCBE-CDBE8557097C Q40649706-FF0BE765-8F6B-493E-9D23-A4C048B2D93A Q40838252-20889A32-1AB8-4E0F-9983-E36E7D328A3C Q40853068-A0CBB0DD-C604-40CA-9DE1-8F69F101F1ED Q41915564-45EB5CFC-CAD5-494E-990A-5CFCA8F75AC1 Q43096522-FCD36685-2845-44B3-9CBD-BBB68E7DE7E1 Q45298736-5AD1CA98-9004-48F2-8E12-594052DD0D4A Q47287966-5AF3AEF3-8E8F-4500-ACDB-15F4D6C739DE Q47309145-17C00CC6-5FEE-49F6-AFFB-083B46DAAEB4 Q47609958-3871BAF5-0738-496A-844A-E34C240000E4 Q47717679-04AB4BF2-E6E2-4A08-AC53-294E8F58188E Q47882128-673338D4-4ED9-4A50-B022-37F7AA5465DC Q48075180-07A97FDE-7CCA-481A-B706-7BE7431D5E33 Q48135712-0658F327-1B83-45D0-A27D-49E991797F90 Q51744524-7D146AEF-CFAE-41F1-8615-5B2BD2A83CD3 Q53414337-D62077D8-0ACB-4768-BBDF-94D747C677BD

P2860

Changes in antidepressant use by young people and suicidal behavior after FDA warnings and media coverage: quasi-experimental study

http://www.wikidata.org/entity/Q33774659

description

2014 nî lūn-bûn

@nan

2014 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Changes in antidepressant use ...... rage: quasi-experimental study

@ast

Changes in antidepressant use ...... rage: quasi-experimental study

@en

type

label

Changes in antidepressant use ...... rage: quasi-experimental study

@ast

Changes in antidepressant use ...... rage: quasi-experimental study

@en

prefLabel

Changes in antidepressant use ...... rage: quasi-experimental study

@ast

Changes in antidepressant use ...... rage: quasi-experimental study

@en

P1433

Q33774659-3BB22DAD-E01B-4415-90F9-D3B9EC889DE5

P1476

Q33774659-A6D8CE4D-626B-4D92-B26C-3681685A414D

P2093

Q33774659-21503CF8-CBAF-498A-893D-DE7965B50B05

Q33774659-402378C4-8833-469D-8D42-33EEE2E1289B

Q33774659-42108B59-9F76-43CE-B3F9-B84FB92216B7

Q33774659-4808BCA1-C146-4D28-B443-8CF3D5A9A7D0

Q33774659-525B23EE-343D-40A9-BF62-B83202C2689C

Q33774659-55A0D14C-0C7D-4070-AE38-077848413E5C

Q33774659-62B55EE3-FE4C-490D-A33D-8019C498A929

Q33774659-68789D6C-D1EC-451E-8409-F61BC950DED4

Q33774659-7DCA1D7F-1118-4C5D-A0BC-DB7CECEB0964

Q33774659-7E913365-F4DF-4945-A34F-4AAC18758BA3

P2860

Q33774659-081511D6-F9FC-4450-955C-40D5330EC03D

Q33774659-177057D4-9FCC-48C7-A7EC-7DC349B7ED9D

Q33774659-226ACD48-B1D8-404B-8CCD-F2AC76A29C96

Q33774659-23D5D2D2-EAC4-4968-BFA0-FDD22F186118

Q33774659-24EE5801-A74A-468C-8289-3E57AF2919E9

Q33774659-2BCAFB27-6B29-471E-81A2-EB44C8556877

Q33774659-2F81C9CF-114B-4955-B3FC-925F6F58520E

Q33774659-341B373C-42D8-4E78-B7A8-D4D1E0E3B5EF

Q33774659-3E73829F-89DE-4BB4-B93D-879665CF1DC4

Q33774659-67B109E8-FE0E-42E9-B81F-54137C0510A7

P304

Q33774659-5D135474-C816-4045-891D-6EB70841629A

P31

Q33774659-59CA4F5E-4C52-4DDE-9F38-D33218EADC44

P356

Q33774659-BBB200AD-04FE-4AE2-9414-293FD4C2E4EC

P407

Q33774659-A0948B45-AC2F-40F8-98A2-AF4ECFCAC380

P478

Q33774659-4C4A03C1-0212-41B1-B9DB-721E398B6F2C

P50

Q33774659-278A0C07-AB8C-4CA7-81FC-12096419E05D

P577

Q33774659-94B17FE0-FCCC-4814-AD44-640D5EC8B089

P5875

Q33774659-D91D2A65-6CB4-4A97-932D-E06A62C60563

P698

Q33774659-AAA743B8-6586-4130-AC1A-7A981F44D11A

P921

Q33774659-4D103782-83B6-4E47-8402-8628942F0D75

Q33774659-513388F1-DD66-4600-9871-734BACEB0488

Q33774659-84509683-0FE3-4D23-B7BA-7BB670764C55

P932

Q33774659-603C30E1-977C-4409-8940-E45B04D08255

P356

P1433

P1476

Changes in antidepressant use ...... rage: quasi-experimental study

@en

P2093

Ashli Owen-Smith

http://www.w3.org/2001/XMLSchema#string

Beth Waitzfelder

http://www.w3.org/2001/XMLSchema#string

Brian K Ahmedani

http://www.w3.org/2001/XMLSchema#string

Christine Y Lu

http://www.w3.org/2001/XMLSchema#string

Donna Rusinak

http://www.w3.org/2001/XMLSchema#string

Enid M Hunkeler

http://www.w3.org/2001/XMLSchema#string

Fang Zhang

http://www.w3.org/2001/XMLSchema#string

Gregory Clarke

http://www.w3.org/2001/XMLSchema#string

Gregory Simon

http://www.w3.org/2001/XMLSchema#string

Jeanne M Madden

http://www.w3.org/2001/XMLSchema#string

P2860

Suicidal thoughts and behavior with antidepressant treatment: reanalysis of the randomized placebo-controlled studies of fluoxetine and venlafaxine

The flawed basis for FDA post-marketing safety decisions: the example of anti-depressants and children

How complete are E-codes in commercial plan claims databases?

Identifying physician-recognized depression from administrative data: consequences for quality measurement.

Antidepressants and suicide risk: how did specific information in FDA safety warnings affect treatment patterns?

Variation in the risk of suicide attempts and completed suicides by antidepressant agent in adults: a propensity score-adjusted analysis of 9 years' data

News coverage of FDA warnings on pediatric antidepressant use and suicidality

A systematic review of validated methods for identifying depression using administrative data.

Youth risk behavior surveillance - United States, 2011.

Antidepressants and the risk of suicidal behaviors.

P304

g3596

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/BMJ.G3596

http://www.w3.org/2001/XMLSchema#string

P407

P478

348

http://www.w3.org/2001/XMLSchema#string

P50

Rebecca C. Rossom

P577

2014-06-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

263325070

http://www.w3.org/2001/XMLSchema#string

P698

24942789

http://www.w3.org/2001/XMLSchema#string

P921

suicide prevention

P932

4062705

http://www.w3.org/2001/XMLSchema#string